Which has the lower trailing P/E, ABBV or AZN?

AZN has the lower trailing P/E: ABBV trades at 125.98 and AZN at 12.77. P/E is one valuation measure and does not by itself establish which business is cheaper.

Which has grown faster, ABBV or AZN?

Over the past five years, AZN grew revenue faster — ABBV at a 4.59% CAGR versus AZN at 16.99%.

Does ABBV or AZN pay a bigger dividend?

ABBV yields 2.62% and AZN yields 1.89% based on trailing dividends and the latest price.

Is ABBV or AZN more profitable?

AZN runs the higher net margin — ABBV at 5.79% versus AZN at 17.19%.

How have ABBV and AZN total returns compared?

Over the past 10 years, ABBV delivered 19.57% and AZN delivered 13.96% annualized total return. Past performance doesn't predict future results.

AbbVie Inc. (ABBV) vs AstraZeneca PLC (AZN)

A side-by-side comparison of AbbVie Inc. and AstraZeneca PLC across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of July 28, 2026. Differences are shown without an overall score or investment verdict.

ABBV

AbbVie Inc.

$465.51B

$263.48HealthcareDelayed quote: Jul 28, 2026, 4:00 PM EDT

AZN

AstraZeneca PLC

$133.67B

$172.48HealthcareDelayed quote: Jul 28, 2026, 7:53 PM EDT

Total return — ABBV vs AZN

growth of $100 · dividends reinvested · last 14y

ABBV +1164.7%AZN +456.2%ABBV compounded faster

ABBV AZN

ABBV vs AZN: by the numbers

•ABBV is the larger company ($465.51B vs $133.67B market cap).
•AZN trades at the lower trailing earnings multiple (12.77 vs 125.98 P/E), one valuation lens rather than an overall verdict.
•AZN converts more revenue to profit (17.19% vs 5.79% net margin).
•AZN grew revenue faster over the past five years (16.99% vs 4.59% CAGR).
•ABBV pays the higher dividend yield (2.62% vs 1.89%).

Metrics side by side

Valuation

Metric	ABBV	AZN
P/E ratio	125.98	12.77
Forward P/E	N/A	16.58
P/S ratio	7.26	2.19
P/B ratio	16.57	2.80
PEG ratio	N/A	0.29
EV / EBITDA	20.46	7.89
FCF yield	4.58%	6.09%

Profitability

Metric	ABBV	AZN
Gross margin	70.68%	81.68%
Operating margin	27.60%	23.69%
Net margin	5.79%	17.19%
ROE	13.23%	21.95%
ROIC	12.97%	13.03%

Dividends

Metric	ABBV	AZN
Dividend yield	2.62%	1.89%
Payout ratio	284.39%	24.24%

Growth (annualized)

Metric	ABBV	AZN
Revenue CAGR (5Y)	4.59%	16.99%
EPS CAGR (5Y)	-2.79%	22.02%
FCF CAGR (5Y)	3.24%	15.68%
Total return CAGR (5Y)	21.24%	10.56%

Frequently asked

Which has the lower trailing P/E, ABBV or AZN?: AZN has the lower trailing P/E: ABBV trades at 125.98 and AZN at 12.77. P/E is one valuation measure and does not by itself establish which business is cheaper.
Which has grown faster, ABBV or AZN?: Over the past five years, AZN grew revenue faster — ABBV at a 4.59% CAGR versus AZN at 16.99%.
Does ABBV or AZN pay a bigger dividend?: ABBV yields 2.62% and AZN yields 1.89% based on trailing dividends and the latest price.
Is ABBV or AZN more profitable?: AZN runs the higher net margin — ABBV at 5.79% versus AZN at 17.19%.
How have ABBV and AZN total returns compared?: Over the past 10 years, ABBV delivered 19.57% and AZN delivered 13.96% annualized total return. Past performance doesn't predict future results.

Go deeper

Full ABBV analysis Full AZN analysis Interactive comparison tool

Dig into the metrics

AbbVie P/E ratio AstraZeneca P/E ratio AbbVie dividend yield AstraZeneca dividend yield AbbVie ROE AstraZeneca ROE AbbVie operating margin AstraZeneca operating margin AbbVie revenue growth AstraZeneca revenue growth AbbVie free cash flow AstraZeneca free cash flow

AbbVie & AstraZeneca appear in these rankings

Highest Dividend Yield Stocks 25+ Year Dividend Growers Fastest Revenue Growth Stocks Highest FCF Yield Stocks

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified July 28, 2026.